SEC Form 4 · accession 0001179110-15-009199
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francois Kress
Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 4, 2015 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $53.26 | Jun 2, 2015 | A | 11,591 | A | — | Jun 2, 2025 | Common Stock | 11,591 | 11,591 | D |
Explanation of responses
- F11/36 of the shares subject to the option vest monthly measured from June 2, 2015 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to continued service through such date.